These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9765358)

  • 1. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells.
    Ryan RR; Weber HC; Mantey SA; Hou W; Hilburger ME; Pradhan TK; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 1998 Oct; 287(1):366-80. PubMed ID: 9765358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
    Katsuno T; Pradhan TK; Ryan RR; Mantey SA; Hou W; Donohue PJ; Akeson MA; Spindel ER; Battey JF; Coy DH; Jensen RT
    Biochemistry; 1999 Jun; 38(22):7307-20. PubMed ID: 10353842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
    Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
    Mantey SA; Coy DH; Entsuah LK; Jensen RT
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM; Nitecki DE; Biancalana S; Feldman RI
    Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
    Mantey SA; Weber HC; Sainz E; Akeson M; Ryan RR; Pradhan TK; Searles RP; Spindel ER; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1997 Oct; 272(41):26062-71. PubMed ID: 9325344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
    Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
    J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
    Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    Wu JM; Hoang DO; Feldman RI
    Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional characterization of hemorphins VV-H-7 and LVV-H-7 as low-affinity agonists for the orphan bombesin receptor subtype 3.
    Lammerich HP; Busmann A; Kutzleb C; Wendland M; Seiler P; Berger C; Eickelmann P; Meyer M; Forssmann WG; Maronde E
    Br J Pharmacol; 2003 Apr; 138(8):1431-40. PubMed ID: 12721098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
    Williams BY; Schonbrunn A
    Cancer Res; 1994 Feb; 54(3):818-24. PubMed ID: 8306345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
    Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
    Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
    Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
    Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of cloned human bombesin receptors.
    Benya RV; Kusui T; Pradhan TK; Battey JF; Jensen RT
    Mol Pharmacol; 1995 Jan; 47(1):10-20. PubMed ID: 7838118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368.
    Ryan RR; Katsuno T; Mantey SA; Pradhan TK; Weber HC; Coy DH; Battey JF; Jensen RT
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1202-11. PubMed ID: 10454496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of bombesin receptor subtype-3 stimulates adhesion of lung cancer cells.
    Hou X; Wei L; Harada A; Tatamoto K
    Lung Cancer; 2006 Nov; 54(2):143-8. PubMed ID: 16979789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor.
    Frucht H; Jensen RT; Dexter D; Yang WL; Xiao Y
    Clin Cancer Res; 1999 Sep; 5(9):2532-9. PubMed ID: 10499630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
    Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
    J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of inositol phospholipid signaling and Ca2+ efflux in human breast cancer cells by bombesin.
    Patel KV; Schrey MP
    Cancer Res; 1990 Jan; 50(2):235-9. PubMed ID: 2153048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
    Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
    Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.